AR019274A1 - Uso de nanodispersiones en formulaciones farmaceuticas finales - Google Patents

Uso de nanodispersiones en formulaciones farmaceuticas finales

Info

Publication number
AR019274A1
AR019274A1 ARP990102160A ARP990102160A AR019274A1 AR 019274 A1 AR019274 A1 AR 019274A1 AR P990102160 A ARP990102160 A AR P990102160A AR P990102160 A ARP990102160 A AR P990102160A AR 019274 A1 AR019274 A1 AR 019274A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical formulations
alpha
final pharmaceutical
nanodispersions
nanodispersion
Prior art date
Application number
ARP990102160A
Other languages
English (en)
Spanish (es)
Original Assignee
Ciba Sc Holding Ag
Vesifact Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Sc Holding Ag, Vesifact Ag filed Critical Ciba Sc Holding Ag
Publication of AR019274A1 publication Critical patent/AR019274A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP990102160A 1998-05-11 1999-05-07 Uso de nanodispersiones en formulaciones farmaceuticas finales AR019274A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810422 1998-05-11

Publications (1)

Publication Number Publication Date
AR019274A1 true AR019274A1 (es) 2002-02-13

Family

ID=8236078

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102160A AR019274A1 (es) 1998-05-11 1999-05-07 Uso de nanodispersiones en formulaciones farmaceuticas finales

Country Status (20)

Country Link
US (2) US7081253B2 (https=)
EP (1) EP0956853B1 (https=)
JP (1) JP4755742B2 (https=)
KR (1) KR100622285B1 (https=)
CN (1) CN1220483C (https=)
AR (1) AR019274A1 (https=)
AT (1) ATE312597T1 (https=)
AU (1) AU767896B2 (https=)
BR (1) BRPI9902068B8 (https=)
CZ (1) CZ166999A3 (https=)
DE (1) DE59912910D1 (https=)
ES (1) ES2253871T3 (https=)
HU (1) HUP9901570A2 (https=)
ID (1) ID22565A (https=)
MY (1) MY133019A (https=)
PL (1) PL332934A1 (https=)
RU (1) RU2224505C2 (https=)
SG (1) SG71923A1 (https=)
TW (1) TWI241915B (https=)
ZA (1) ZA993200B (https=)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908309D0 (en) * 1999-04-12 1999-06-02 Phares Pharm Res Nv Lipid aggregate forming compositions and their use
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
RU2200558C1 (ru) * 2002-04-23 2003-03-20 Нестерук Владимир Викторович Лекарственное средство, содержащее финастерид
AT6609U3 (de) * 2003-04-07 2004-04-26 Unipack Ges M B H Abfuell Und Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
WO2005117830A1 (en) * 2004-06-04 2005-12-15 Camurus Ab Liquid depot formulations
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
DE112006001898B4 (de) * 2005-07-21 2013-05-08 National Institute For Materials Science Vorrichtung zur Inhalation von Arzneimitteln
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
NZ572601A (en) 2006-03-29 2012-03-30 Univ Wayne State Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP4840031B2 (ja) 2006-08-31 2011-12-21 ソニー株式会社 ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CL2008000037A1 (es) * 2007-01-16 2008-10-10 Bayer Consumer Care Ag Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US9545384B2 (en) 2007-06-04 2017-01-17 Bend Research, Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
CN100536826C (zh) * 2007-12-28 2009-09-09 清华大学 一种绵羊油纳米乳液及其制备方法和应用
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
FR2949063B1 (fr) * 2009-08-11 2011-09-30 Pf Medicament Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
CN102277748A (zh) * 2010-06-12 2011-12-14 罗莱家纺股份有限公司 纳米维生素微胶囊整理剂的使用方法
KR101494594B1 (ko) * 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP3583954A1 (en) * 2018-06-19 2019-12-25 neubourg skin care GmbH Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
EP4065108B1 (en) 2019-11-25 2025-08-06 The Johns Hopkins University Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors
CN111388744B (zh) * 2020-01-15 2021-05-18 华中科技大学 一种凝胶贮库及其制法与制备术后止血制剂的应用
CA3170810A1 (en) * 2020-02-11 2021-08-19 Advent Therapeutics Inc. Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them
US20230310386A1 (en) * 2020-05-20 2023-10-05 Intervet Inc. Injectable pharmaceutical compositions and uses thereof
CA3185481A1 (en) * 2020-06-01 2021-12-09 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
MX2022016437A (es) 2020-06-30 2023-01-30 Chong Kun Dang Pharmaceutical Corp Composicion inyectable que comprende un analogo de gnrh.
WO2024165166A1 (en) 2023-02-10 2024-08-15 Tetra Pharm Technologies A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150990A1 (de) 1981-12-23 1983-06-30 A. Nattermann & Cie GmbH, 5000 Köln Neue pflanzenschutzmittelsuspensionskonzentrate
US4675193A (en) * 1983-10-31 1987-06-23 Borden, Inc. Cheese-flavored substance and method of producing same
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
US4965357A (en) 1986-08-07 1990-10-23 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg 2,5,6-substituted N1 -alkylpyrimidines
DE3852409T2 (de) 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
DE68917544T2 (de) 1988-06-20 1994-12-15 Shiseido Co Ltd Durchsichtiges Präparat.
CA1337397C (en) * 1988-09-29 1995-10-24 Hideo Nakajima Emulsified composition
FR2648462B1 (fr) 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
CH677886A5 (https=) * 1989-06-26 1991-07-15 Hans Georg Prof Dr Weder
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
ZA925581B (en) * 1991-07-26 1993-05-14 Smithkline Beecham Corp Pharmaceutical microemulsions.
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH685674A5 (de) 1993-12-19 1995-09-15 Marigen Sa Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen.
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
PE52896A1 (es) * 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
EP0711557A1 (de) 1994-11-09 1996-05-15 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage
EP0733358A3 (de) * 1995-03-21 1998-05-20 Novartis AG Intravenös applizierbare Nanosuspensionen
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
DE19522693A1 (de) 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
JP3508314B2 (ja) * 1995-08-18 2004-03-22 大正製薬株式会社 ビタミンｃを配合した液剤
AU7689996A (en) * 1995-12-12 1997-07-03 Vesifact Ag Cortisone spray for topical administration
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
DE59710082D1 (de) * 1996-12-13 2003-06-18 Vesifact Ag Baar Kosmetische Präparate in Form einer Nanodispersion
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Also Published As

Publication number Publication date
EP0956853B1 (de) 2005-12-14
EP0956853A2 (de) 1999-11-17
AU2805099A (en) 1999-11-18
PL332934A1 (en) 1999-11-22
US7081253B2 (en) 2006-07-25
JP4755742B2 (ja) 2011-08-24
ID22565A (id) 1999-11-11
JPH11335266A (ja) 1999-12-07
HU9901570D0 (en) 1999-07-28
SG71923A1 (en) 2000-04-18
CN1235017A (zh) 1999-11-17
US7871642B2 (en) 2011-01-18
ATE312597T1 (de) 2005-12-15
RU2224505C2 (ru) 2004-02-27
BRPI9902068B8 (pt) 2021-05-25
MY133019A (en) 2007-10-31
TWI241915B (en) 2005-10-21
CZ166999A3 (cs) 1999-11-17
BR9902068A (pt) 2000-06-06
CN1220483C (zh) 2005-09-28
KR19990088156A (ko) 1999-12-27
EP0956853A3 (de) 2000-01-05
KR100622285B1 (ko) 2006-09-11
DE59912910D1 (de) 2006-01-19
AU767896B2 (en) 2003-11-27
BR9902068B1 (pt) 2014-10-29
US20060292191A1 (en) 2006-12-28
ZA993200B (en) 1999-11-11
ES2253871T3 (es) 2006-06-01
US20030190347A1 (en) 2003-10-09
HUP9901570A2 (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
AR019274A1 (es) Uso de nanodispersiones en formulaciones farmaceuticas finales
MY133152A (en) Use of nanodispersions in cosmetic end formulations
AR026569A1 (es) Auxiliar humectante concentrado pobre en espuma, su empleo y procedimiento para su elaboracion
UY26496A1 (es) Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco
HN2000000267A (es) Oxazolidinonas substituidas y su uso
UY23801A1 (es) Formulacion lista acuosa, monofasica, estable para sustancias activas fitosanitarias y un procedimiento para su obtencion
AR024013A1 (es) Preparado farmaceutico con diamorfina como sustancia activa, y su utilizacion en un procedimiento para el tratamiento de la adiccion a los opiaceos
PE20011299A1 (es) Emulsiones estables para productos cosmeticos
ES2154660T3 (es) Catalizadores soportados.
MX169328B (es) Sistema para mezclar y distribuir concreto
CL2004001255A1 (es) Formulacion liquida herbicida que contiene (a) uno o mas derivados de acidos policarboxilicos y (b) uno o mas compuestos activos inhibidores de als, procedimiento de para preparar la formulacion que comprende el mezclado de los componentes y metodo p
ES8505626A1 (es) Procedimiento para preparar una composicion de enlechado de multiples componentes
ES2166552T3 (es) Uso de polisacaridos del bloque g.
ES2170759T3 (es) Derivados de galantamina, un procedimiento para su preparacion y su uso como medicamentos.
ES2021131B3 (es) Pistas o placas de plastico homogeneas, en especial de estructura policroma, asi como proceso de obtencion.
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
ES2117385T3 (es) Estructura absorbente por osmosis y capilaridad con densidad diferencial y procedimiento para su fabricacion.
ES2183200T3 (es) Granulados aplicables por via oral de derivados de hexahidropirazina.
AR022273A1 (es) Preparacion de evaporacion termica y metodo para evaporar sustancias quimicas por medio del uso de la misma
ES2176452T3 (es) Composicion para la liberacion controlada de ingredientes activos dependiente de ph y procedimientos para su fabricacion.
ES2193134T3 (es) Procedimiento para la preparacion de dispersiones de vesiculas encapsuladas.
ES2171110A1 (es) Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
AR019325A1 (es) COMPOSICION TINTOREA QUE CONTIENE UNA PIRAZOLO-[1,5-a]-PIRIMIDINA COMO BASE DE OXIDACION Y UN ACOPLADOR NAFTALENICO, Y PROCEDIMIENTOS DE TINTURA
ES2194994T3 (es) Procedimiento para la obtencion de caprolactama.
ES8306593A1 (es) Procedimiento de preparar agentes farmaceuticos administra- bles por via topica

Legal Events

Date Code Title Description
FG Grant, registration